Should Drug Approval Decisions Consider Cost?

Article

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

J.PMorgan Chase estimated that global sales of this drug could teach $1.6 billion next year and $4.2 billion by 2020. That's a lot of money for a medication that some members of an FDA advisory committee believed had modest effectiveness.

This drug’s hefty price tag raises a few questions, including:

  • How long can our health care system sustain high prices for drug that only benefit a small number of patients?
  • Will some type of drug rationing result from the high costs?
  • Will there be legislation that requires drug approvals based on cost effectiveness?

What do you think?

Related Videos
BillionPhotos.com - stock.adobe.com
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Image credit: Fabio Balbi | stock.adobe.com
Image credit: Melita - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.